drugset
drugset / Trial / NCT05456152

Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia

NCT05456152 ↗

Phase 3 Unknown 358 enrolled EMS
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of sublingual zolpidem during the long-term treatment of insomnia.

Timeline

Start
2024-06
Primary completion
2025-01
Completion
2025-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 5 mg Other

Indications

insomnia